Latest Us Expansion News

First Graphene accelerates its US expansion by acquiring MITO Material Solutions, gaining functionalised graphene technologies and a direct commercial foothold in the world’s largest defence and aerospace market.

Vitrafy Life Sciences has teamed up with Vitalant Innovation Center to tackle the impending gap in red blood cell cryopreservation technology in the US, aiming to replace soon-to-be-discontinued legacy methods and potentially expand into other blood products.

DroneShield has landed a $24.9 million contract with the US Department of War’s Joint Interagency Task Force 401 to supply mobile and fixed counter-drone solutions, reinforcing its foothold in the US defence market.

QuickFee Limited has reported a robust 77% increase in Australian originations for Q4 FY26 to-date, driven by strong Fee Funding and Disbursement Funding growth. The company boosted its Australian credit facility by A$15 million, signalling confidence in its low-risk lending model, while US operations focus on reseller channel expansion amid a product embedding delay.

Optiscan and Mayo Clinic have completed all key engineering milestones in their two-year partnership to develop a digital endomicroscopic imaging system for robotic surgery, extending their agreement to support further clinical and commercial planning.

Austco Healthcare expects FY26 revenue between A$90 million and A$95 million, driven by strong sales and a significant US rollout. Net profit after tax is forecast to jump over 50%, supported by operational growth and a one-off benefit.

Bubs Australia expects FY26 revenue between $105 million and $115 million, with underlying EBITDA forecast at $4 million to $8 million despite external challenges including regulatory delays and increased air freight costs.

Omnia Metals has identified Beaver Creek within its Montana Radix Project as the key focus for rare earth and niobium exploration, leveraging historical data and planning detailed field validation.

Evion Group confirms high-grade fluorspar assays up to 88.15% CaF2 at its Carp Project in Nevada, validating a large, near-surface mineralised system. The company plans an extensive exploration program to capitalise on the US critical minerals demand.

PainChek has secured A$5.5 million via convertible notes to accelerate its US sales expansion and strengthen working capital amid key commercial milestones.

Mach7 Technologies has secured a five-year, A$1.7 million subscription contract with US teleradiology provider AMRADNET, slashing deployment time from 12 months to just 45 days.

Serko Limited posted a 34% jump in total income to NZD 120.9 million for FY26, powered by strong Booking.com for Business growth and a full year of GetThere revenue. The company’s EBITDAFI surged 137%, while net loss narrowed. Serko.ai’s US closed beta marks a strategic pivot into AI-driven business travel.